Mineralys Therapeutics (MLYS) Shareholder's Equity (2022 - 2026)
Mineralys Therapeutics (MLYS) Shareholder's Equity (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
502.95 Mn |
| 10 |
Mineralys Therapeutics |
1.95 Bn |
1.95 Bn |
- |
638.14 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
638.14 Mn |
| Dec 31, 2025 |
646.69 Mn |
| Sep 30, 2025 |
576.43 Mn |
| Jun 30, 2025 |
313.55 Mn |
| Mar 31, 2025 |
341.56 Mn |
| Dec 31, 2024 |
191.26 Mn |
| Sep 30, 2024 |
236.93 Mn |
| Jun 30, 2024 |
290.10 Mn |
| Mar 31, 2024 |
328.05 Mn |
| Dec 31, 2023 |
241.15 Mn |
| Sep 30, 2023 |
264.01 Mn |
| Jun 30, 2023 |
285.01 Mn |
| Mar 31, 2023 |
295.88 Mn |
| Dec 31, 2022 |
-52.27 Mn |
| Sep 30, 2022 |
-43.41 Mn |
| Jun 30, 2022 |
-36.93 Mn |
| Mar 31, 2022 |
-30.48 Mn |
